ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomised, controlled, open‐label, cross‐over trial
Diabetes Obesity and Metabolism
◽
10.1111/dom.14574
◽
2021
◽
Author(s):
Ulrik Pedersen‐Bjergaard
◽
Rikke M. Agesen
◽
Julie M. B. Brøsen
◽
Amra C. Alibegovic
◽
Henrik U. Andersen
◽
...
Keyword(s):
Type 1 Diabetes
◽
Severe Hypoglycaemia
◽
Insulin Degludec
◽
Open Label
◽
Randomised Controlled
Download Full-text
Related Documents
Cited By
References
Comparison of Treatment with Insulin Degludec and Glargine U100 in Patients with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycaemia (HypoDeg): A Prospective, Randomized, Open-Label, Crossover Trial
SSRN Electronic Journal
◽
10.2139/ssrn.3690928
◽
2020
◽
Author(s):
Rikke Agesen
◽
Amra Ciric Alibegovic
◽
Henrik Ullits Andersen
◽
Henning Beck-Nielsen
◽
Peter Gustenhoff
◽
...
Keyword(s):
Type 1 Diabetes
◽
Crossover Trial
◽
Severe Hypoglycaemia
◽
Insulin Degludec
◽
Open Label
Download Full-text
Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
The Lancet
◽
10.1016/s0140-6736(18)30297-6
◽
2018
◽
Vol 391
(10128)
◽
pp. 1367-1377
◽
Cited By ~ 141
Author(s):
Lutz Heinemann
◽
Guido Freckmann
◽
Dominic Ehrmann
◽
Gabriele Faber-Heinemann
◽
Stefania Guerra
◽
...
Keyword(s):
Type 1 Diabetes
◽
Randomised Controlled Trial
◽
Severe Hypoglycaemia
◽
Controlled Trial
◽
Glucose Monitoring
◽
Randomised Controlled
◽
Multiple Daily Insulin Injections
◽
Impaired Hypoglycaemia Awareness
◽
Hypoglycaemia Awareness
Download Full-text
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
The Lancet
◽
10.1016/s0140-6736(12)60204-9
◽
2012
◽
Vol 379
(9825)
◽
pp. 1489-1497
◽
Cited By ~ 221
Author(s):
Simon Heller
◽
John Buse
◽
Miles Fisher
◽
Satish Garg
◽
Michel Marre
◽
...
Keyword(s):
Type 1 Diabetes
◽
Insulin Glargine
◽
Insulin Aspart
◽
Insulin Degludec
◽
Treat To Target
◽
Open Label
◽
Phase 3
◽
Mealtime Insulin
◽
Basal Bolus
Download Full-text
Basal Insulin degludec and GLycemic control ComparEd to Aspart via insulin Pump in type 1 diabetes (BIGLEAP): a single-center, open-label, randomized, crossover trial.
Endocrine Practice
◽
10.1016/j.eprac.2021.11.001
◽
2021
◽
Author(s):
Wendy S. Lane
◽
Stephen L. Weinrib
◽
Michael J. Lawrence
◽
Benjamin C. Lane
◽
Ryan T. Jarrett
Keyword(s):
Type 1 Diabetes
◽
Glycemic Control
◽
Basal Insulin
◽
Crossover Trial
◽
Insulin Pump
◽
Insulin Degludec
◽
Single Center
◽
Open Label
◽
Randomized Crossover Trial
Download Full-text
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial
The Lancet Diabetes & Endocrinology
◽
10.1016/s2213-8587(19)30150-0
◽
2019
◽
Vol 7
(6)
◽
pp. 462-472
◽
Cited By ~ 21
Author(s):
Emanuele Bosi
◽
Pratik Choudhary
◽
Harold W de Valk
◽
Sandrine Lablanche
◽
Javier Castañeda
◽
...
Keyword(s):
Type 1 Diabetes
◽
Randomised Controlled Trial
◽
Insulin Pump
◽
Controlled Trial
◽
Efficacy And Safety
◽
Open Label
◽
Randomised Controlled
Download Full-text
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design
BMC Endocrine Disorders
◽
10.1186/s12902-019-0408-x
◽
2019
◽
Vol 19
(1)
◽
Cited By ~ 1
Author(s):
Rikke Mette Agesen
◽
Amra Ciric Alibegovic
◽
Henrik Ullits Andersen
◽
Henning Beck-Nielsen
◽
Peter Gustenhoff
◽
...
Keyword(s):
Type 1 Diabetes
◽
High Risk
◽
Severe Hypoglycaemia
◽
Insulin Degludec
◽
Nocturnal Hypoglycaemia
Download Full-text
Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, phase 3, randomized, open-label, treat-to-target trial
Diabetes Care
◽
10.2337/dc11-2503
◽
2012
◽
Vol 35
(11)
◽
pp. 2174-2181
◽
Cited By ~ 49
Author(s):
I. B. Hirsch
◽
B. Bode
◽
J.-P. Courreges
◽
P. Dykiel
◽
E. Franek
◽
...
Keyword(s):
Type 1 Diabetes
◽
Insulin Aspart
◽
Insulin Degludec
◽
Treat To Target
◽
Target Trial
◽
Open Label
◽
Phase 3
◽
Once Daily
◽
Basal Bolus
Download Full-text
Efficacy and safety of insulin degludec given as part of basal–bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26‐week randomized, open‐label, treat‐to‐target non‐inferiority trial
Diabetes Obesity and Metabolism
◽
10.1111/dom.12298
◽
2014
◽
Vol 16
(10)
◽
pp. 922-930
◽
Cited By ~ 29
Author(s):
M. J. Davies
◽
J. L. Gross
◽
Y. Ono
◽
T. Sasaki
◽
G. Bantwal
◽
...
Keyword(s):
Type 1 Diabetes
◽
Insulin Aspart
◽
Insulin Degludec
◽
Treat To Target
◽
Efficacy And Safety
◽
Open Label
◽
Mealtime Insulin
◽
Basal Bolus
Download Full-text
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial
The Lancet Diabetes & Endocrinology
◽
10.1016/s2213-8587(18)30078-0
◽
2018
◽
Vol 6
(7)
◽
pp. 527-537
◽
Cited By ~ 40
Author(s):
Sandrine Lablanche
◽
Marie-Christine Vantyghem
◽
Laurence Kessler
◽
Anne Wojtusciszyn
◽
Sophie Borot
◽
...
Keyword(s):
Type 1 Diabetes
◽
Kidney Transplantation
◽
Randomised Controlled Trial
◽
Insulin Therapy
◽
Islet Transplantation
◽
Severe Hypoglycaemia
◽
Controlled Trial
◽
Randomised Controlled
Download Full-text
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial
The Lancet Digital Health
◽
10.1016/s2589-7500(19)30003-2
◽
2019
◽
Vol 1
(1)
◽
pp. e17-e25
◽
Cited By ~ 35
Author(s):
Pierre-Yves Benhamou
◽
Sylvia Franc
◽
Yves Reznik
◽
Charles Thivolet
◽
Pauline Schaepelynck
◽
...
Keyword(s):
Type 1 Diabetes
◽
Closed Loop
◽
Crossover Trial
◽
Real Life
◽
Insulin Delivery
◽
Open Label
◽
Life Conditions
◽
Randomised Controlled
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close